"","gs_name","disease","Mean"
"1","HALLMARK_ANGIOGENESIS","Lung Squamous Cell Carcinoma",0.000548678409011106
"2","HALLMARK_HEDGEHOG_SIGNALING","Stomach Adenocarcinoma",0.000516361654135312
"3","HALLMARK_PANCREAS_BETA_CELLS","Colon Adenocarcinoma",0.000511341180136016
"4","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Colon Adenocarcinoma",0.000492883017629287
"5","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Stomach Adenocarcinoma",0.000477577073493122
"6","HALLMARK_PANCREAS_BETA_CELLS","Stomach Adenocarcinoma",0.000469029324222727
"7","HALLMARK_ANGIOGENESIS","Stomach Adenocarcinoma",0.000458951538684186
"8","HALLMARK_HEDGEHOG_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000454633924475251
"9","HALLMARK_MYC_TARGETS_V2","Bladder Urothelial Carcinoma",0.000450368164895986
"10","HALLMARK_HEDGEHOG_SIGNALING","Colon Adenocarcinoma",0.000443560929459016
"11","HALLMARK_ANDROGEN_RESPONSE","Stomach Adenocarcinoma",0.00043262124230214
"12","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000416502858878988
"13","HALLMARK_IL6_JAK_STAT3_SIGNALING","Bladder Urothelial Carcinoma",0.000406180251823358
"14","HALLMARK_SPERMATOGENESIS","Lung Squamous Cell Carcinoma",0.000400284216454109
"15","HALLMARK_TGF_BETA_SIGNALING","Colon Adenocarcinoma",0.000397888075398363
"16","HALLMARK_TGF_BETA_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000392966557409024
"17","HALLMARK_APOPTOSIS","Stomach Adenocarcinoma",0.000392556652512529
"18","HALLMARK_ANGIOGENESIS","Brain Lower Grade Glioma",0.000391697916874767
"19","HALLMARK_HEDGEHOG_SIGNALING","Lung Squamous Cell Carcinoma",0.00039158572009765
"20","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Lung Adenocarcinoma",0.00038751063793983
"21","HALLMARK_TGF_BETA_SIGNALING","Bladder Urothelial Carcinoma",0.000385829481777712
"22","HALLMARK_TGF_BETA_SIGNALING","Lung Squamous Cell Carcinoma",0.000380225459254974
"23","HALLMARK_IL6_JAK_STAT3_SIGNALING","Lung Squamous Cell Carcinoma",0.000379923880574864
"24","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Bladder Urothelial Carcinoma",0.000377121990635272
"25","HALLMARK_UV_RESPONSE_DN","Bladder Urothelial Carcinoma",0.000376095347308346
"26","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Bladder Urothelial Carcinoma",0.000374280974756922
"27","HALLMARK_KRAS_SIGNALING_UP","Skin Cutaneous Melanoma",0.000371239302493646
"28","HALLMARK_ANGIOGENESIS","Skin Cutaneous Melanoma",0.000368790234094138
"29","HALLMARK_PANCREAS_BETA_CELLS","Bladder Urothelial Carcinoma",0.000364163270341119
"30","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Bladder Urothelial Carcinoma",0.00036245186653557
"31","HALLMARK_G2M_CHECKPOINT","Bladder Urothelial Carcinoma",0.000362446603811493
"32","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Bladder Urothelial Carcinoma",0.000359579922170135
"33","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Stomach Adenocarcinoma",0.000359349537610884
"34","HALLMARK_ANGIOGENESIS","Head and Neck Squamous Cell Carcinoma",0.000358887261848128
"35","HALLMARK_IL6_JAK_STAT3_SIGNALING","Liver Hepatocellular Carcinoma",0.000356845217639372
"36","HALLMARK_ANGIOGENESIS","Liver Hepatocellular Carcinoma",0.000356482921136814
"37","HALLMARK_MYC_TARGETS_V2","Ovarian Serous Cystadenocarcinoma",0.000355812941172821
"38","HALLMARK_PEROXISOME","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000354528996890243
"39","HALLMARK_KRAS_SIGNALING_DN","Bladder Urothelial Carcinoma",0.00035381672763308
"40","HALLMARK_HEDGEHOG_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000353762828684472
"41","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000353394646149175
"42","HALLMARK_APOPTOSIS","Bladder Urothelial Carcinoma",0.000353259139801861
"43","HALLMARK_ANGIOGENESIS","Kidney Renal Clear Cell Carcinoma",0.000352233149111274
"44","HALLMARK_ANDROGEN_RESPONSE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000350976667099898
"45","HALLMARK_ANGIOGENESIS","Lung Adenocarcinoma",0.000350583903350401
"46","HALLMARK_DNA_REPAIR","Skin Cutaneous Melanoma",0.000349837660102948
"47","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Skin Cutaneous Melanoma",0.000348192670670634
"48","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Colon Adenocarcinoma",0.000347525205038906
"49","HALLMARK_ESTROGEN_RESPONSE_EARLY","Lung Squamous Cell Carcinoma",0.000346789848648595
"50","HALLMARK_TGF_BETA_SIGNALING","Stomach Adenocarcinoma",0.000344286410063715
"51","HALLMARK_P53_PATHWAY","Lung Squamous Cell Carcinoma",0.000343454878185032
"52","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Lung Squamous Cell Carcinoma",0.000341589260231066
"53","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Lung Squamous Cell Carcinoma",0.000341454017965742
"54","HALLMARK_MYOGENESIS","Bladder Urothelial Carcinoma",0.000339485188783749
"55","HALLMARK_ESTROGEN_RESPONSE_LATE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000338190342129336
"56","HALLMARK_ALLOGRAFT_REJECTION","Bladder Urothelial Carcinoma",0.000337751352379078
"57","HALLMARK_KRAS_SIGNALING_DN","Lung Squamous Cell Carcinoma",0.000337011426967771
"58","HALLMARK_ESTROGEN_RESPONSE_LATE","Bladder Urothelial Carcinoma",0.000335828560010975
"59","HALLMARK_ESTROGEN_RESPONSE_EARLY","Bladder Urothelial Carcinoma",0.000335156712417754
"60","HALLMARK_HEME_METABOLISM","Skin Cutaneous Melanoma",0.000335045005814691
"61","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Stomach Adenocarcinoma",0.000334817427399055
"62","HALLMARK_ANDROGEN_RESPONSE","Ovarian Serous Cystadenocarcinoma",0.000333651218499151
"63","HALLMARK_UV_RESPONSE_UP","Bladder Urothelial Carcinoma",0.000333473146338248
"64","HALLMARK_UV_RESPONSE_DN","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000332542218764622
"65","HALLMARK_MTORC1_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000331900219055173
"66","HALLMARK_P53_PATHWAY","Bladder Urothelial Carcinoma",0.000331757482379639
"67","HALLMARK_MYC_TARGETS_V2","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.00033158024716558
"68","HALLMARK_INTERFERON_GAMMA_RESPONSE","Bladder Urothelial Carcinoma",0.00033133921286164
"69","HALLMARK_APICAL_SURFACE","Skin Cutaneous Melanoma",0.00033077461615241
"70","HALLMARK_P53_PATHWAY","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000330099441150932
"71","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Skin Cutaneous Melanoma",0.000328847631636699
"72","HALLMARK_HEDGEHOG_SIGNALING","Bladder Urothelial Carcinoma",0.000328737542530616
"73","HALLMARK_HEME_METABOLISM","Bladder Urothelial Carcinoma",0.000327513647574241
"74","HALLMARK_IL6_JAK_STAT3_SIGNALING","Stomach Adenocarcinoma",0.00032658838487219
"75","HALLMARK_COAGULATION","Stomach Adenocarcinoma",0.000326424652728741
"76","HALLMARK_ANDROGEN_RESPONSE","Colon Adenocarcinoma",0.000324156908938964
"77","HALLMARK_IL6_JAK_STAT3_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000323931638976866
"78","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000323630217956116
"79","HALLMARK_ANGIOGENESIS","Ovarian Serous Cystadenocarcinoma",0.000323361087082619
"80","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000322619027595207
"81","HALLMARK_MYOGENESIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000322504260323265
"82","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Skin Cutaneous Melanoma",0.000321359278105702
"83","HALLMARK_UV_RESPONSE_DN","Lung Squamous Cell Carcinoma",0.000321257576714926
"84","HALLMARK_KRAS_SIGNALING_UP","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000320580989461053
"85","HALLMARK_MTORC1_SIGNALING","Bladder Urothelial Carcinoma",0.000320379969909665
"86","HALLMARK_ESTROGEN_RESPONSE_EARLY","Lung Adenocarcinoma",0.000318933385225702
"87","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Bladder Urothelial Carcinoma",0.000318885773252949
"88","HALLMARK_INFLAMMATORY_RESPONSE","Bladder Urothelial Carcinoma",0.00031807809376771
"89","HALLMARK_NOTCH_SIGNALING","Bladder Urothelial Carcinoma",0.000317627138082616
"90","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Stomach Adenocarcinoma",0.000317156727853588
"91","HALLMARK_PROTEIN_SECRETION","Lung Squamous Cell Carcinoma",0.000316653974037277
"92","HALLMARK_SPERMATOGENESIS","Skin Cutaneous Melanoma",0.00031543814819471
"93","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.00031530807608394
"94","HALLMARK_E2F_TARGETS","Bladder Urothelial Carcinoma",0.000314967778298467
"95","HALLMARK_IL2_STAT5_SIGNALING","Stomach Adenocarcinoma",0.000313927774241
"96","HALLMARK_SPERMATOGENESIS","Head and Neck Squamous Cell Carcinoma",0.000313863810354399
"97","HALLMARK_P53_PATHWAY","Head and Neck Squamous Cell Carcinoma",0.000313417627596177
"98","HALLMARK_IL2_STAT5_SIGNALING","Bladder Urothelial Carcinoma",0.000313218559027105
"99","HALLMARK_MYC_TARGETS_V2","Liver Hepatocellular Carcinoma",0.000312921223909517
"100","HALLMARK_ESTROGEN_RESPONSE_LATE","Lung Squamous Cell Carcinoma",0.000312745417803146
"101","HALLMARK_ANDROGEN_RESPONSE","Skin Cutaneous Melanoma",0.000312738435461327
"102","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Stomach Adenocarcinoma",0.000310600630202844
"103","HALLMARK_SPERMATOGENESIS","Lung Adenocarcinoma",0.000310299128423873
"104","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Kidney Renal Papillary Cell Carcinoma",0.000310194983848069
"105","HALLMARK_PROTEIN_SECRETION","Skin Cutaneous Melanoma",0.000309677280946712
"106","HALLMARK_KRAS_SIGNALING_DN","Skin Cutaneous Melanoma",0.000308149912372318
"107","HALLMARK_INTERFERON_GAMMA_RESPONSE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000307839001782916
"108","HALLMARK_HYPOXIA","Stomach Adenocarcinoma",0.000307797574976709
"109","HALLMARK_APICAL_SURFACE","Lung Squamous Cell Carcinoma",0.00030752425928102
"110","HALLMARK_HYPOXIA","Lung Squamous Cell Carcinoma",0.000307520626945137
"111","HALLMARK_KRAS_SIGNALING_DN","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000307206283769676
"112","HALLMARK_GLYCOLYSIS","Bladder Urothelial Carcinoma",0.000307017952041546
"113","HALLMARK_UV_RESPONSE_DN","Stomach Adenocarcinoma",0.000305639106358318
"114","HALLMARK_G2M_CHECKPOINT","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000304269054233094
"115","HALLMARK_P53_PATHWAY","Skin Cutaneous Melanoma",0.00030389652370082
"116","HALLMARK_TGF_BETA_SIGNALING","Liver Hepatocellular Carcinoma",0.000303385670063732
"117","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Bladder Urothelial Carcinoma",0.000303019538260993
"118","HALLMARK_ANDROGEN_RESPONSE","Bladder Urothelial Carcinoma",0.000302178614616856
"119","HALLMARK_MYC_TARGETS_V1","Ovarian Serous Cystadenocarcinoma",0.000301021621253945
"120","HALLMARK_UV_RESPONSE_DN","Colon Adenocarcinoma",0.000300696682504722
"121","HALLMARK_UV_RESPONSE_UP","Ovarian Serous Cystadenocarcinoma",0.000300266187424896
"122","HALLMARK_DNA_REPAIR","Bladder Urothelial Carcinoma",0.000299292325200735
"123","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.00029900607695295
"124","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Lung Squamous Cell Carcinoma",0.000298813986587186
"125","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Colon Adenocarcinoma",0.000298756677470483
"126","HALLMARK_MYC_TARGETS_V1","Bladder Urothelial Carcinoma",0.000298710495155685
"127","HALLMARK_IL6_JAK_STAT3_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000298506977219748
"128","HALLMARK_ESTROGEN_RESPONSE_EARLY","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000297955676398113
"129","HALLMARK_DNA_REPAIR","Ovarian Serous Cystadenocarcinoma",0.000297436821847778
"130","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Ovarian Serous Cystadenocarcinoma",0.000295748077880739
"131","HALLMARK_GLYCOLYSIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000295417684575784
"132","HALLMARK_MITOTIC_SPINDLE","Ovarian Serous Cystadenocarcinoma",0.000295376388098459
"133","HALLMARK_UV_RESPONSE_UP","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000294907622631979
"134","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Kidney Renal Papillary Cell Carcinoma",0.000294382237795682
"135","HALLMARK_TGF_BETA_SIGNALING","Lung Adenocarcinoma",0.000294246140991315
"136","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Skin Cutaneous Melanoma",0.000294029552158668
"137","HALLMARK_ADIPOGENESIS","Bladder Urothelial Carcinoma",0.000293662302051141
"138","HALLMARK_DNA_REPAIR","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000293428372752153
"139","HALLMARK_IL2_STAT5_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000291266676284961
"140","HALLMARK_FATTY_ACID_METABOLISM","Skin Cutaneous Melanoma",0.000290689801842293
"141","HALLMARK_MTORC1_SIGNALING","Skin Cutaneous Melanoma",0.000290357369532234
"142","HALLMARK_APOPTOSIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000290063818239353
"143","HALLMARK_MTORC1_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000289958869648756
"144","HALLMARK_INFLAMMATORY_RESPONSE","Head and Neck Squamous Cell Carcinoma",0.000289514102104735
"145","HALLMARK_HEDGEHOG_SIGNALING","Brain Lower Grade Glioma",0.000288955611173139
"146","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Stomach Adenocarcinoma",0.000288265283814086
"147","HALLMARK_INFLAMMATORY_RESPONSE","Lung Squamous Cell Carcinoma",0.000287766713478849
"148","HALLMARK_IL6_JAK_STAT3_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000287373184044223
"149","HALLMARK_MYC_TARGETS_V2","Kidney Renal Papillary Cell Carcinoma",0.000286931512115004
"150","HALLMARK_MYC_TARGETS_V2","Kidney Renal Clear Cell Carcinoma",0.000286918889540122
"151","HALLMARK_ALLOGRAFT_REJECTION","Skin Cutaneous Melanoma",0.000286439439692741
"152","HALLMARK_G2M_CHECKPOINT","Ovarian Serous Cystadenocarcinoma",0.000286359689384557
"153","HALLMARK_ESTROGEN_RESPONSE_LATE","Lung Adenocarcinoma",0.000286317120847825
"154","HALLMARK_MYOGENESIS","Skin Cutaneous Melanoma",0.000285846315417394
"155","HALLMARK_KRAS_SIGNALING_DN","Ovarian Serous Cystadenocarcinoma",0.000285382489339296
"156","HALLMARK_PROTEIN_SECRETION","Lung Adenocarcinoma",0.000284825099867129
"157","HALLMARK_P53_PATHWAY","Liver Hepatocellular Carcinoma",0.000284816176540069
"158","HALLMARK_UV_RESPONSE_DN","Ovarian Serous Cystadenocarcinoma",0.000284815696989905
"159","HALLMARK_ESTROGEN_RESPONSE_EARLY","Skin Cutaneous Melanoma",0.000284460475398822
"160","HALLMARK_INTERFERON_GAMMA_RESPONSE","Skin Cutaneous Melanoma",0.000284387859281877
"161","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Ovarian Serous Cystadenocarcinoma",0.000284377750472631
"162","HALLMARK_COMPLEMENT","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000284172854431858
"163","HALLMARK_COMPLEMENT","Bladder Urothelial Carcinoma",0.000284138379801756
"164","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Stomach Adenocarcinoma",0.000283724714476612
"165","HALLMARK_BILE_ACID_METABOLISM","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000283646193530524
"166","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Skin Cutaneous Melanoma",0.000283520822554081
"167","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000283379930766819
"168","HALLMARK_INTERFERON_ALPHA_RESPONSE","Lung Squamous Cell Carcinoma",0.000283352233370083
"169","HALLMARK_KRAS_SIGNALING_UP","Lung Squamous Cell Carcinoma",0.000283038429172561
"170","HALLMARK_MYOGENESIS","Ovarian Serous Cystadenocarcinoma",0.000282278429873032
"171","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Lung Squamous Cell Carcinoma",0.000282128214691908
"172","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Bladder Urothelial Carcinoma",0.000281567358222167
"173","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Lung Squamous Cell Carcinoma",0.000281367629595842
"174","HALLMARK_INFLAMMATORY_RESPONSE","Stomach Adenocarcinoma",0.00028054412498055
"175","HALLMARK_MTORC1_SIGNALING","Lung Squamous Cell Carcinoma",0.000280080120789855
"176","HALLMARK_UV_RESPONSE_DN","Skin Cutaneous Melanoma",0.000279234492637829
"177","HALLMARK_INFLAMMATORY_RESPONSE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000278902877073782
"178","HALLMARK_PROTEIN_SECRETION","Head and Neck Squamous Cell Carcinoma",0.00027841761386786
"179","HALLMARK_P53_PATHWAY","Ovarian Serous Cystadenocarcinoma",0.000278169977596325
"180","HALLMARK_ESTROGEN_RESPONSE_EARLY","Stomach Adenocarcinoma",0.000278093446204606
"181","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Ovarian Serous Cystadenocarcinoma",0.000277852825493328
"182","HALLMARK_FATTY_ACID_METABOLISM","Lung Adenocarcinoma",0.000277712274789377
"183","HALLMARK_ESTROGEN_RESPONSE_LATE","Skin Cutaneous Melanoma",0.000277509632270552
"184","HALLMARK_ALLOGRAFT_REJECTION","Ovarian Serous Cystadenocarcinoma",0.000277181162699791
"185","HALLMARK_GLYCOLYSIS","Head and Neck Squamous Cell Carcinoma",0.000277111139473219
"186","HALLMARK_ANDROGEN_RESPONSE","Lung Squamous Cell Carcinoma",0.000277036938177906
"187","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000276970918716616
"188","HALLMARK_PROTEIN_SECRETION","Ovarian Serous Cystadenocarcinoma",0.000276714380700774
"189","HALLMARK_ADIPOGENESIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000275778739590839
"190","HALLMARK_ESTROGEN_RESPONSE_LATE","Head and Neck Squamous Cell Carcinoma",0.000275609607185708
"191","HALLMARK_KRAS_SIGNALING_DN","Lung Adenocarcinoma",0.000275479569094159
"192","HALLMARK_MITOTIC_SPINDLE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000275228816338559
"193","HALLMARK_E2F_TARGETS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.00027432003772104
"194","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Head and Neck Squamous Cell Carcinoma",0.000274216782068418
"195","HALLMARK_INTERFERON_ALPHA_RESPONSE","Bladder Urothelial Carcinoma",0.00027359283110547
"196","HALLMARK_COMPLEMENT","Skin Cutaneous Melanoma",0.000272721369760807
"197","HALLMARK_MYC_TARGETS_V1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000272647671062839
"198","HALLMARK_APOPTOSIS","Colon Adenocarcinoma",0.000272535904619009
"199","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Lung Adenocarcinoma",0.000272307119373369
"200","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Ovarian Serous Cystadenocarcinoma",0.000272249459231865
"201","HALLMARK_MYC_TARGETS_V1","Liver Hepatocellular Carcinoma",0.000272089785427396
"202","HALLMARK_INFLAMMATORY_RESPONSE","Skin Cutaneous Melanoma",0.000271707099833644
"203","HALLMARK_MYC_TARGETS_V2","Stomach Adenocarcinoma",0.000271670144440895
"204","HALLMARK_G2M_CHECKPOINT","Liver Hepatocellular Carcinoma",0.000271246494286566
"205","HALLMARK_P53_PATHWAY","Lung Adenocarcinoma",0.00027105808738404
"206","HALLMARK_APOPTOSIS","Skin Cutaneous Melanoma",0.000270429629692236
"207","HALLMARK_GLYCOLYSIS","Skin Cutaneous Melanoma",0.0002703082609028
"208","HALLMARK_MITOTIC_SPINDLE","Skin Cutaneous Melanoma",0.000269892657806511
"209","HALLMARK_TGF_BETA_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000269887507639145
"210","HALLMARK_ADIPOGENESIS","Ovarian Serous Cystadenocarcinoma",0.000269240815544594
"211","HALLMARK_ALLOGRAFT_REJECTION","Lung Squamous Cell Carcinoma",0.000267267708025444
"212","HALLMARK_KRAS_SIGNALING_DN","Colon Adenocarcinoma",0.000267048523976255
"213","HALLMARK_APICAL_JUNCTION","Bladder Urothelial Carcinoma",0.000266650850480687
"214","HALLMARK_P53_PATHWAY","Colon Adenocarcinoma",0.000266507313000401
"215","HALLMARK_IL2_STAT5_SIGNALING","Lung Squamous Cell Carcinoma",0.000266360754390729
"216","HALLMARK_IL6_JAK_STAT3_SIGNALING","Skin Cutaneous Melanoma",0.000266261060321372
"217","HALLMARK_HYPOXIA","Head and Neck Squamous Cell Carcinoma",0.000265307779249932
"218","HALLMARK_IL6_JAK_STAT3_SIGNALING","Lung Adenocarcinoma",0.000264376932016099
"219","HALLMARK_SPERMATOGENESIS","Bladder Urothelial Carcinoma",0.000264263024171428
"220","HALLMARK_G2M_CHECKPOINT","Kidney Renal Papillary Cell Carcinoma",0.000264085364111292
"221","HALLMARK_FATTY_ACID_METABOLISM","Bladder Urothelial Carcinoma",0.000263886952579423
"222","HALLMARK_HEME_METABOLISM","Ovarian Serous Cystadenocarcinoma",0.000263870074098851
"223","HALLMARK_E2F_TARGETS","Skin Cutaneous Melanoma",0.000263864262668369
"224","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Skin Cutaneous Melanoma",0.000263664129299381
"225","HALLMARK_G2M_CHECKPOINT","Skin Cutaneous Melanoma",0.000262487054365897
"226","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Lung Squamous Cell Carcinoma",0.000262297864152767
"227","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Kidney Renal Clear Cell Carcinoma",0.000262000554551683
"228","HALLMARK_SPERMATOGENESIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000261939520669447
"229","HALLMARK_HYPOXIA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000261763628326987
"230","HALLMARK_ANGIOGENESIS","Bladder Urothelial Carcinoma",0.000261522868658263
"231","HALLMARK_IL2_STAT5_SIGNALING","Skin Cutaneous Melanoma",0.000260721099034744
"232","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000260533171371863
"233","HALLMARK_APICAL_JUNCTION","Skin Cutaneous Melanoma",0.000259543468332852
"234","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Skin Cutaneous Melanoma",0.000259536164589413
"235","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Lung Adenocarcinoma",0.000259306526905045
"236","HALLMARK_MYOGENESIS","Liver Hepatocellular Carcinoma",0.000258594835423522
"237","HALLMARK_ALLOGRAFT_REJECTION","Stomach Adenocarcinoma",0.000258060667037145
"238","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Lung Adenocarcinoma",0.000257993722231321
"239","HALLMARK_ADIPOGENESIS","Head and Neck Squamous Cell Carcinoma",0.000257496833296983
"240","HALLMARK_ALLOGRAFT_REJECTION","Liver Hepatocellular Carcinoma",0.000257393862081165
"241","HALLMARK_MYOGENESIS","Lung Squamous Cell Carcinoma",0.000257155674565266
"242","HALLMARK_KRAS_SIGNALING_DN","Stomach Adenocarcinoma",0.000256981423909367
"243","HALLMARK_ESTROGEN_RESPONSE_EARLY","Ovarian Serous Cystadenocarcinoma",0.000256780868045709
"244","HALLMARK_COAGULATION","Ovarian Serous Cystadenocarcinoma",0.000256603019154479
"245","HALLMARK_MYC_TARGETS_V2","Brain Lower Grade Glioma",0.000255866636460649
"246","HALLMARK_FATTY_ACID_METABOLISM","Head and Neck Squamous Cell Carcinoma",0.000255525940637065
"247","HALLMARK_APOPTOSIS","Lung Squamous Cell Carcinoma",0.000255422006644145
"248","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Liver Hepatocellular Carcinoma",0.000255078943311161
"249","HALLMARK_GLYCOLYSIS","Brain Lower Grade Glioma",0.000255059693337475
"250","HALLMARK_ANGIOGENESIS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000255051698197014
"251","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Liver Hepatocellular Carcinoma",0.000254709051302254
"252","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000253896730401979
"253","HALLMARK_ADIPOGENESIS","Skin Cutaneous Melanoma",0.000253431539265405
"254","HALLMARK_SPERMATOGENESIS","Colon Adenocarcinoma",0.000253243586497906
"255","HALLMARK_KRAS_SIGNALING_UP","Bladder Urothelial Carcinoma",0.000252815010364369
"256","HALLMARK_APICAL_JUNCTION","Colon Adenocarcinoma",0.00025244350649973
"257","HALLMARK_XENOBIOTIC_METABOLISM","Skin Cutaneous Melanoma",0.000251993746540752
"258","HALLMARK_ANDROGEN_RESPONSE","Brain Lower Grade Glioma",0.000251790264097708
"259","HALLMARK_ANDROGEN_RESPONSE","Liver Hepatocellular Carcinoma",0.000251744825903275
"260","HALLMARK_ALLOGRAFT_REJECTION","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000251462651325054
"261","HALLMARK_MYOGENESIS","Kidney Renal Papillary Cell Carcinoma",0.000251084606282362
"262","HALLMARK_GLYCOLYSIS","Kidney Renal Papillary Cell Carcinoma",0.000251047215921381
"263","HALLMARK_KRAS_SIGNALING_UP","Stomach Adenocarcinoma",0.000250386704895092
"264","HALLMARK_ALLOGRAFT_REJECTION","Colon Adenocarcinoma",0.000250082152486469
"265","HALLMARK_MTORC1_SIGNALING","Lung Adenocarcinoma",0.000250071460762476
"266","HALLMARK_UV_RESPONSE_DN","Lung Adenocarcinoma",0.000249610027754912
"267","HALLMARK_INTERFERON_ALPHA_RESPONSE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000249577951702206
"268","HALLMARK_ALLOGRAFT_REJECTION","Head and Neck Squamous Cell Carcinoma",0.000249290118114678
"269","HALLMARK_ESTROGEN_RESPONSE_EARLY","Head and Neck Squamous Cell Carcinoma",0.000249090627109603
"270","HALLMARK_XENOBIOTIC_METABOLISM","Lung Squamous Cell Carcinoma",0.000248507026275269
"271","HALLMARK_APICAL_SURFACE","Head and Neck Squamous Cell Carcinoma",0.000247012783298447
"272","HALLMARK_PANCREAS_BETA_CELLS","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000246759340016527
"273","HALLMARK_IL6_JAK_STAT3_SIGNALING","Colon Adenocarcinoma",0.000246649147255758
"274","HALLMARK_TGF_BETA_SIGNALING","Brain Lower Grade Glioma",0.000246510682856511
"275","HALLMARK_APOPTOSIS","Ovarian Serous Cystadenocarcinoma",0.00024635244387743
"276","HALLMARK_HYPOXIA","Bladder Urothelial Carcinoma",0.000245881771449614
"277","HALLMARK_APICAL_JUNCTION","Lung Adenocarcinoma",0.000245616583267402
"278","HALLMARK_APICAL_JUNCTION","Head and Neck Squamous Cell Carcinoma",0.000245534536600498
"279","HALLMARK_MYOGENESIS","Lung Adenocarcinoma",0.000245131709270568
"280","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Head and Neck Squamous Cell Carcinoma",0.000245114226782973
"281","HALLMARK_COMPLEMENT","Stomach Adenocarcinoma",0.000245092405023818
"282","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Lung Squamous Cell Carcinoma",0.000245037596513242
"283","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Brain Lower Grade Glioma",0.000244614086236879
"284","HALLMARK_IL2_STAT5_SIGNALING","Liver Hepatocellular Carcinoma",0.000244403020158864
"285","HALLMARK_COMPLEMENT","Ovarian Serous Cystadenocarcinoma",0.000244161845056467
"286","HALLMARK_COAGULATION","Lung Squamous Cell Carcinoma",0.000243331272694351
"287","HALLMARK_MYOGENESIS","Colon Adenocarcinoma",0.000243282884028307
"288","HALLMARK_DNA_REPAIR","Lung Squamous Cell Carcinoma",0.000243214831527291
"289","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Lung Squamous Cell Carcinoma",0.000243186903847039
"290","HALLMARK_PROTEIN_SECRETION","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000242835547436368
"291","HALLMARK_COAGULATION","Bladder Urothelial Carcinoma",0.00024282076648971
"292","HALLMARK_KRAS_SIGNALING_UP","Colon Adenocarcinoma",0.000242697886931594
"293","HALLMARK_FATTY_ACID_METABOLISM","Stomach Adenocarcinoma",0.000242428488438485
"294","HALLMARK_INTERFERON_ALPHA_RESPONSE","Head and Neck Squamous Cell Carcinoma",0.000242373748932973
"295","HALLMARK_PEROXISOME","Ovarian Serous Cystadenocarcinoma",0.000242148100879052
"296","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Kidney Renal Clear Cell Carcinoma",0.000242140195144835
"297","HALLMARK_PANCREAS_BETA_CELLS","Skin Cutaneous Melanoma",0.000241796444174014
"298","HALLMARK_MYC_TARGETS_V1","Kidney Renal Papillary Cell Carcinoma",0.000241701182135391
"299","HALLMARK_SPERMATOGENESIS","Stomach Adenocarcinoma",0.000240661738813786
"300","HALLMARK_KRAS_SIGNALING_UP","Ovarian Serous Cystadenocarcinoma",0.000240056572647755
"301","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Colon Adenocarcinoma",0.000239794689827918
"302","HALLMARK_HYPOXIA","Ovarian Serous Cystadenocarcinoma",0.000239453271171969
"303","HALLMARK_HEME_METABOLISM","Lung Squamous Cell Carcinoma",0.00023942173579414
"304","HALLMARK_COMPLEMENT","Head and Neck Squamous Cell Carcinoma",0.000239371938288357
"305","HALLMARK_ADIPOGENESIS","Stomach Adenocarcinoma",0.000238891532193472
"306","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Ovarian Serous Cystadenocarcinoma",0.0002388593658074
"307","HALLMARK_XENOBIOTIC_METABOLISM","Ovarian Serous Cystadenocarcinoma",0.000238106483833892
"308","HALLMARK_PEROXISOME","Skin Cutaneous Melanoma",0.000238093371136687
"309","HALLMARK_XENOBIOTIC_METABOLISM","Bladder Urothelial Carcinoma",0.000237718952304105
"310","HALLMARK_XENOBIOTIC_METABOLISM","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000237478034965918
"311","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Brain Lower Grade Glioma",0.000236838185009431
"312","HALLMARK_PROTEIN_SECRETION","Stomach Adenocarcinoma",0.000236459063134633
"313","HALLMARK_PANCREAS_BETA_CELLS","Ovarian Serous Cystadenocarcinoma",0.000235554837468838
"314","HALLMARK_IL6_JAK_STAT3_SIGNALING","Brain Lower Grade Glioma",0.00023496049756589
"315","HALLMARK_G2M_CHECKPOINT","Head and Neck Squamous Cell Carcinoma",0.000234774265776728
"316","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000233594412454452
"317","HALLMARK_HEDGEHOG_SIGNALING","Liver Hepatocellular Carcinoma",0.000233501951435182
"318","HALLMARK_BILE_ACID_METABOLISM","Liver Hepatocellular Carcinoma",0.000233472337758624
"319","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Head and Neck Squamous Cell Carcinoma",0.000233085157451034
"320","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Skin Cutaneous Melanoma",0.000232727912827572
"321","HALLMARK_NOTCH_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000232322549278081
"322","HALLMARK_PROTEIN_SECRETION","Brain Lower Grade Glioma",0.000232286815272894
"323","HALLMARK_HYPOXIA","Lung Adenocarcinoma",0.000232126877478426
"324","HALLMARK_MYC_TARGETS_V1","Skin Cutaneous Melanoma",0.000231953017203896
"325","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000231922025030308
"326","HALLMARK_COAGULATION","Lung Adenocarcinoma",0.000230944040012251
"327","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Brain Lower Grade Glioma",0.00023050548397954
"328","HALLMARK_ANDROGEN_RESPONSE","Lung Adenocarcinoma",0.000230179869079399
"329","HALLMARK_FATTY_ACID_METABOLISM","Ovarian Serous Cystadenocarcinoma",0.000229388871596215
"330","HALLMARK_INTERFERON_ALPHA_RESPONSE","Skin Cutaneous Melanoma",0.000229010182280149
"331","HALLMARK_INTERFERON_GAMMA_RESPONSE","Ovarian Serous Cystadenocarcinoma",0.000228548384313252
"332","HALLMARK_KRAS_SIGNALING_DN","Head and Neck Squamous Cell Carcinoma",0.000227353884483936
"333","HALLMARK_UV_RESPONSE_DN","Head and Neck Squamous Cell Carcinoma",0.000227033037824659
"334","HALLMARK_HEDGEHOG_SIGNALING","Skin Cutaneous Melanoma",0.000227022658792708
"335","HALLMARK_MYC_TARGETS_V2","Head and Neck Squamous Cell Carcinoma",0.000226733408704405
"336","HALLMARK_COAGULATION","Colon Adenocarcinoma",0.000226375264014189
"337","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Head and Neck Squamous Cell Carcinoma",0.000226066525798593
"338","HALLMARK_PEROXISOME","Head and Neck Squamous Cell Carcinoma",0.000226033115144892
"339","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Head and Neck Squamous Cell Carcinoma",0.00022561617064134
"340","HALLMARK_G2M_CHECKPOINT","Brain Lower Grade Glioma",0.000224608836423127
"341","HALLMARK_FATTY_ACID_METABOLISM","Lung Squamous Cell Carcinoma",0.000224390332752876
"342","HALLMARK_PEROXISOME","Stomach Adenocarcinoma",0.000224206602147024
"343","HALLMARK_MTORC1_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000223913866016412
"344","HALLMARK_MITOTIC_SPINDLE","Lung Squamous Cell Carcinoma",0.000223552540325407
"345","HALLMARK_HYPOXIA","Skin Cutaneous Melanoma",0.000223008577823499
"346","HALLMARK_MITOTIC_SPINDLE","Stomach Adenocarcinoma",0.000222920296189069
"347","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Brain Lower Grade Glioma",0.000222333457957328
"348","HALLMARK_E2F_TARGETS","Liver Hepatocellular Carcinoma",0.00022212989782839
"349","HALLMARK_MYC_TARGETS_V2","Skin Cutaneous Melanoma",0.000222061915209113
"350","HALLMARK_MITOTIC_SPINDLE","Bladder Urothelial Carcinoma",0.000221459057661856
"351","HALLMARK_INFLAMMATORY_RESPONSE","Ovarian Serous Cystadenocarcinoma",0.000221297997548314
"352","HALLMARK_UV_RESPONSE_DN","Brain Lower Grade Glioma",0.000221216045187424
"353","HALLMARK_TGF_BETA_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.00022115389707728
"354","HALLMARK_ESTROGEN_RESPONSE_EARLY","Colon Adenocarcinoma",0.000220872494996849
"355","HALLMARK_APICAL_SURFACE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000220732712126397
"356","HALLMARK_UV_RESPONSE_UP","Colon Adenocarcinoma",0.000220479862842351
"357","HALLMARK_UV_RESPONSE_UP","Lung Adenocarcinoma",0.000220133053210574
"358","HALLMARK_KRAS_SIGNALING_UP","Brain Lower Grade Glioma",0.000220076519079439
"359","HALLMARK_ANDROGEN_RESPONSE","Head and Neck Squamous Cell Carcinoma",0.00021976857900339
"360","HALLMARK_APOPTOSIS","Head and Neck Squamous Cell Carcinoma",0.000219164028347726
"361","HALLMARK_MYC_TARGETS_V1","Brain Lower Grade Glioma",0.000219080926119047
"362","HALLMARK_IL2_STAT5_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000218892782526885
"363","HALLMARK_INTERFERON_GAMMA_RESPONSE","Stomach Adenocarcinoma",0.000218626941054742
"364","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Liver Hepatocellular Carcinoma",0.000218616497061911
"365","HALLMARK_MTORC1_SIGNALING","Brain Lower Grade Glioma",0.000218285674886969
"366","HALLMARK_MYOGENESIS","Stomach Adenocarcinoma",0.000217878612056102
"367","HALLMARK_ADIPOGENESIS","Lung Adenocarcinoma",0.000217763850658732
"368","HALLMARK_ESTROGEN_RESPONSE_LATE","Liver Hepatocellular Carcinoma",0.000217574957858745
"369","HALLMARK_ESTROGEN_RESPONSE_LATE","Stomach Adenocarcinoma",0.000217429256672325
"370","HALLMARK_E2F_TARGETS","Kidney Renal Papillary Cell Carcinoma",0.000217389217857365
"371","HALLMARK_G2M_CHECKPOINT","Lung Adenocarcinoma",0.000217297808377605
"372","HALLMARK_INTERFERON_ALPHA_RESPONSE","Liver Hepatocellular Carcinoma",0.000217021094577318
"373","HALLMARK_INFLAMMATORY_RESPONSE","Lung Adenocarcinoma",0.000216904146432507
"374","HALLMARK_XENOBIOTIC_METABOLISM","Lung Adenocarcinoma",0.000216691763815923
"375","HALLMARK_UV_RESPONSE_UP","Head and Neck Squamous Cell Carcinoma",0.000216600366012377
"376","HALLMARK_FATTY_ACID_METABOLISM","Colon Adenocarcinoma",0.000216552862003752
"377","HALLMARK_IL2_STAT5_SIGNALING","Brain Lower Grade Glioma",0.000216374097743074
"378","HALLMARK_SPERMATOGENESIS","Brain Lower Grade Glioma",0.000215519394487756
"379","HALLMARK_P53_PATHWAY","Stomach Adenocarcinoma",0.000215142102730532
"380","HALLMARK_COMPLEMENT","Lung Adenocarcinoma",0.000215054589324543
"381","HALLMARK_BILE_ACID_METABOLISM","Ovarian Serous Cystadenocarcinoma",0.000214970381328113
"382","HALLMARK_MYOGENESIS","Head and Neck Squamous Cell Carcinoma",0.000214534691056087
"383","HALLMARK_APICAL_JUNCTION","Ovarian Serous Cystadenocarcinoma",0.000214473591080147
"384","HALLMARK_HYPOXIA","Brain Lower Grade Glioma",0.000213833176657157
"385","HALLMARK_GLYCOLYSIS","Colon Adenocarcinoma",0.000213782700888896
"386","HALLMARK_XENOBIOTIC_METABOLISM","Colon Adenocarcinoma",0.000213120644133426
"387","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Colon Adenocarcinoma",0.00021308745478707
"388","HALLMARK_APICAL_SURFACE","Ovarian Serous Cystadenocarcinoma",0.000212925767339354
"389","HALLMARK_MYOGENESIS","Kidney Renal Clear Cell Carcinoma",0.000212727236653587
"390","HALLMARK_PEROXISOME","Colon Adenocarcinoma",0.000212700945776842
"391","HALLMARK_UV_RESPONSE_UP","Liver Hepatocellular Carcinoma",0.00021177846054501
"392","HALLMARK_KRAS_SIGNALING_UP","Lung Adenocarcinoma",0.000211727831189016
"393","HALLMARK_SPERMATOGENESIS","Ovarian Serous Cystadenocarcinoma",0.000211701744633858
"394","HALLMARK_P53_PATHWAY","Brain Lower Grade Glioma",0.000211676096183855
"395","HALLMARK_COMPLEMENT","Lung Squamous Cell Carcinoma",0.00021157611022555
"396","HALLMARK_COAGULATION","Head and Neck Squamous Cell Carcinoma",0.000210868518210345
"397","HALLMARK_APICAL_JUNCTION","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000210220053039417
"398","HALLMARK_HEDGEHOG_SIGNALING","Kidney Renal Clear Cell Carcinoma",0.000209824784689557
"399","HALLMARK_ESTROGEN_RESPONSE_LATE","Ovarian Serous Cystadenocarcinoma",0.000209520914784049
"400","HALLMARK_IL2_STAT5_SIGNALING","Lung Adenocarcinoma",0.000209167682810779
"401","HALLMARK_COMPLEMENT","Colon Adenocarcinoma",0.000208968723574735
"402","HALLMARK_KRAS_SIGNALING_DN","Brain Lower Grade Glioma",0.000208493203416904
"403","HALLMARK_E2F_TARGETS","Head and Neck Squamous Cell Carcinoma",0.000208481601922281
"404","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Liver Hepatocellular Carcinoma",0.000208230564972094
"405","HALLMARK_BILE_ACID_METABOLISM","Bladder Urothelial Carcinoma",0.000208136651653238
"406","HALLMARK_XENOBIOTIC_METABOLISM","Head and Neck Squamous Cell Carcinoma",0.000207803742030331
"407","HALLMARK_NOTCH_SIGNALING","Brain Lower Grade Glioma",0.000207616233361823
"408","HALLMARK_APICAL_JUNCTION","Brain Lower Grade Glioma",0.000207476170123986
"409","HALLMARK_UV_RESPONSE_UP","Lung Squamous Cell Carcinoma",0.000206718221023468
"410","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Ovarian Serous Cystadenocarcinoma",0.000206626790277584
"411","HALLMARK_HEDGEHOG_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000205826503762804
"412","HALLMARK_PEROXISOME","Lung Squamous Cell Carcinoma",0.000205796862687609
"413","HALLMARK_GLYCOLYSIS","Lung Squamous Cell Carcinoma",0.00020511459899675
"414","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Lung Adenocarcinoma",0.000204826600216921
"415","HALLMARK_IL2_STAT5_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000204248013659767
"416","HALLMARK_MYOGENESIS","Brain Lower Grade Glioma",0.000203981843375055
"417","HALLMARK_BILE_ACID_METABOLISM","Colon Adenocarcinoma",0.00020381043641231
"418","HALLMARK_HEME_METABOLISM","Lung Adenocarcinoma",0.000203793030351835
"419","HALLMARK_ESTROGEN_RESPONSE_EARLY","Liver Hepatocellular Carcinoma",0.000202868164295334
"420","HALLMARK_MTORC1_SIGNALING","Liver Hepatocellular Carcinoma",0.000202650603488422
"421","HALLMARK_INFLAMMATORY_RESPONSE","Colon Adenocarcinoma",0.000202635238174042
"422","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Stomach Adenocarcinoma",0.000202591178259513
"423","HALLMARK_TGF_BETA_SIGNALING","Skin Cutaneous Melanoma",0.000202588204045304
"424","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Brain Lower Grade Glioma",0.00020246433735085
"425","HALLMARK_G2M_CHECKPOINT","Lung Squamous Cell Carcinoma",0.000201254683244145
"426","HALLMARK_HEME_METABOLISM","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000200658271903598
"427","HALLMARK_INTERFERON_GAMMA_RESPONSE","Head and Neck Squamous Cell Carcinoma",0.000200412613410616
"428","HALLMARK_UV_RESPONSE_UP","Skin Cutaneous Melanoma",0.000200084902013165
"429","HALLMARK_HYPOXIA","Colon Adenocarcinoma",0.000200077092674364
"430","HALLMARK_INTERFERON_GAMMA_RESPONSE","Lung Squamous Cell Carcinoma",0.000199914842730825
"431","HALLMARK_FATTY_ACID_METABOLISM","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000199487458336799
"432","HALLMARK_COAGULATION","Skin Cutaneous Melanoma",0.000199306497227875
"433","HALLMARK_PANCREAS_BETA_CELLS","Lung Squamous Cell Carcinoma",0.00019913699792464
"434","HALLMARK_DNA_REPAIR","Brain Lower Grade Glioma",0.000199050499649853
"435","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Liver Hepatocellular Carcinoma",0.000198757899128017
"436","HALLMARK_ANGIOGENESIS","Colon Adenocarcinoma",0.000198696627465383
"437","HALLMARK_GLYCOLYSIS","Lung Adenocarcinoma",0.000198612983448501
"438","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Liver Hepatocellular Carcinoma",0.000198024946625128
"439","HALLMARK_APICAL_JUNCTION","Lung Squamous Cell Carcinoma",0.000197297322628715
"440","HALLMARK_APICAL_SURFACE","Colon Adenocarcinoma",0.000197153139772228
"441","HALLMARK_GLYCOLYSIS","Ovarian Serous Cystadenocarcinoma",0.000196995588380892
"442","HALLMARK_PEROXISOME","Lung Adenocarcinoma",0.000196976036161712
"443","HALLMARK_PANCREAS_BETA_CELLS","Brain Lower Grade Glioma",0.00019695283264391
"444","HALLMARK_E2F_TARGETS","Ovarian Serous Cystadenocarcinoma",0.000196806333974974
"445","HALLMARK_ADIPOGENESIS","Lung Squamous Cell Carcinoma",0.000196773468837564
"446","HALLMARK_ESTROGEN_RESPONSE_EARLY","Breast Invasive Carcinoma",0.000196551927682814
"447","HALLMARK_APOPTOSIS","Brain Lower Grade Glioma",0.000196483269665553
"448","HALLMARK_G2M_CHECKPOINT","Colon Adenocarcinoma",0.00019599844456379
"449","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Lung Adenocarcinoma",0.000195890023041752
"450","HALLMARK_ALLOGRAFT_REJECTION","Lung Adenocarcinoma",0.000195800581196604
"451","HALLMARK_DNA_REPAIR","Lung Adenocarcinoma",0.000195727390758253
"452","HALLMARK_ESTROGEN_RESPONSE_LATE","Colon Adenocarcinoma",0.000195703273829909
"453","HALLMARK_NOTCH_SIGNALING","Colon Adenocarcinoma",0.00019557497622975
"454","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Kidney Renal Clear Cell Carcinoma",0.000195257442823629
"455","HALLMARK_KRAS_SIGNALING_DN","Liver Hepatocellular Carcinoma",0.000195001801321554
"456","HALLMARK_IL2_STAT5_SIGNALING","Colon Adenocarcinoma",0.000194729293037784
"457","HALLMARK_INTERFERON_GAMMA_RESPONSE","Brain Lower Grade Glioma",0.000193635699309507
"458","HALLMARK_BILE_ACID_METABOLISM","Skin Cutaneous Melanoma",0.000192205409935456
"459","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Brain Lower Grade Glioma",0.000192109182851765
"460","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Lung Adenocarcinoma",0.000191231303422875
"461","HALLMARK_HEME_METABOLISM","Head and Neck Squamous Cell Carcinoma",0.000190431092106417
"462","HALLMARK_HEME_METABOLISM","Colon Adenocarcinoma",0.000189953849020991
"463","HALLMARK_HEME_METABOLISM","Kidney Renal Papillary Cell Carcinoma",0.000189395288308361
"464","HALLMARK_XENOBIOTIC_METABOLISM","Stomach Adenocarcinoma",0.000189378598883475
"465","HALLMARK_MTORC1_SIGNALING","Stomach Adenocarcinoma",0.000188461666030319
"466","HALLMARK_G2M_CHECKPOINT","Kidney Renal Clear Cell Carcinoma",0.000188272408943436
"467","HALLMARK_ALLOGRAFT_REJECTION","Brain Lower Grade Glioma",0.000188263697318606
"468","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.00018632533943111
"469","HALLMARK_G2M_CHECKPOINT","Stomach Adenocarcinoma",0.000186280255526153
"470","HALLMARK_INFLAMMATORY_RESPONSE","Brain Lower Grade Glioma",0.000186205944659026
"471","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Colon Adenocarcinoma",0.000186172219209562
"472","HALLMARK_INFLAMMATORY_RESPONSE","Liver Hepatocellular Carcinoma",0.000186095352461027
"473","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Colon Adenocarcinoma",0.000185799258671916
"474","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Kidney Renal Papillary Cell Carcinoma",0.000184581645248564
"475","HALLMARK_INTERFERON_ALPHA_RESPONSE","Stomach Adenocarcinoma",0.000184361337336594
"476","HALLMARK_BILE_ACID_METABOLISM","Stomach Adenocarcinoma",0.000184198811230407
"477","HALLMARK_MYC_TARGETS_V2","Lung Adenocarcinoma",0.000184159243849984
"478","HALLMARK_BILE_ACID_METABOLISM","Head and Neck Squamous Cell Carcinoma",0.000183969684096444
"479","HALLMARK_APICAL_SURFACE","Lung Adenocarcinoma",0.000183867623421573
"480","HALLMARK_PEROXISOME","Brain Lower Grade Glioma",0.000183690760441184
"481","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Liver Hepatocellular Carcinoma",0.000182305422294816
"482","HALLMARK_XENOBIOTIC_METABOLISM","Liver Hepatocellular Carcinoma",0.000182195310136227
"483","HALLMARK_BILE_ACID_METABOLISM","Lung Squamous Cell Carcinoma",0.000181506358090973
"484","HALLMARK_BILE_ACID_METABOLISM","Brain Lower Grade Glioma",0.000181422962967189
"485","HALLMARK_APOPTOSIS","Liver Hepatocellular Carcinoma",0.000181352520412023
"486","HALLMARK_TGF_BETA_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000180923074113617
"487","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Brain Lower Grade Glioma",0.000180839223628204
"488","HALLMARK_DNA_REPAIR","Head and Neck Squamous Cell Carcinoma",0.000180619715004065
"489","HALLMARK_ANGIOGENESIS","Kidney Renal Papillary Cell Carcinoma",0.000179996747087624
"490","HALLMARK_ESTROGEN_RESPONSE_EARLY","Brain Lower Grade Glioma",0.000179903068628232
"491","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Brain Lower Grade Glioma",0.000179891062585814
"492","HALLMARK_INTERFERON_GAMMA_RESPONSE","Kidney Renal Papillary Cell Carcinoma",0.000179605388899047
"493","HALLMARK_INTERFERON_ALPHA_RESPONSE","Lung Adenocarcinoma",0.000179567345600076
"494","HALLMARK_NOTCH_SIGNALING","Skin Cutaneous Melanoma",0.000179115810768247
"495","HALLMARK_KRAS_SIGNALING_UP","Liver Hepatocellular Carcinoma",0.000178929263243239
"496","HALLMARK_ESTROGEN_RESPONSE_LATE","Breast Invasive Carcinoma",0.000178821404930981
"497","HALLMARK_UV_RESPONSE_UP","Kidney Renal Clear Cell Carcinoma",0.000178663319496152
"498","HALLMARK_PANCREAS_BETA_CELLS","Kidney Renal Papillary Cell Carcinoma",0.000178320208543625
"499","HALLMARK_MYC_TARGETS_V1","Breast Invasive Carcinoma",0.000177957918060902
"500","HALLMARK_MITOTIC_SPINDLE","Kidney Renal Papillary Cell Carcinoma",0.000177424199156809
"501","HALLMARK_IL6_JAK_STAT3_SIGNALING","Breast Invasive Carcinoma",0.000176662920619044
"502","HALLMARK_KRAS_SIGNALING_UP","Head and Neck Squamous Cell Carcinoma",0.000176115784304511
"503","HALLMARK_APOPTOSIS","Lung Adenocarcinoma",0.000175850930570379
"504","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Kidney Renal Clear Cell Carcinoma",0.000175632970414428
"505","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Head and Neck Squamous Cell Carcinoma",0.000175609101330683
"506","HALLMARK_UV_RESPONSE_DN","Breast Invasive Carcinoma",0.000175033910243818
"507","HALLMARK_MITOTIC_SPINDLE","Colon Adenocarcinoma",0.00017472191511289
"508","HALLMARK_HEME_METABOLISM","Brain Lower Grade Glioma",0.000174629855497721
"509","HALLMARK_MYC_TARGETS_V1","Head and Neck Squamous Cell Carcinoma",0.000173629099871891
"510","HALLMARK_MYC_TARGETS_V2","Colon Adenocarcinoma",0.000173278240156806
"511","HALLMARK_GLYCOLYSIS","Liver Hepatocellular Carcinoma",0.000172531544837106
"512","HALLMARK_COAGULATION","Brain Lower Grade Glioma",0.000172022081373859
"513","HALLMARK_MITOTIC_SPINDLE","Lung Adenocarcinoma",0.000171719081119057
"514","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Kidney Renal Papillary Cell Carcinoma",0.000171390755647928
"515","HALLMARK_MTORC1_SIGNALING","Colon Adenocarcinoma",0.000170674225121036
"516","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Kidney Renal Clear Cell Carcinoma",0.000169861360918734
"517","HALLMARK_PEROXISOME","Bladder Urothelial Carcinoma",0.000169796813082828
"518","HALLMARK_INTERFERON_GAMMA_RESPONSE","Lung Adenocarcinoma",0.000169256486732982
"519","HALLMARK_DNA_REPAIR","Stomach Adenocarcinoma",0.000168756191618188
"520","HALLMARK_ESTROGEN_RESPONSE_LATE","Brain Lower Grade Glioma",0.000168233562894363
"521","HALLMARK_INTERFERON_ALPHA_RESPONSE","Brain Lower Grade Glioma",0.000167913953868707
"522","HALLMARK_E2F_TARGETS","Colon Adenocarcinoma",0.000167537201062467
"523","HALLMARK_APICAL_JUNCTION","Kidney Renal Papillary Cell Carcinoma",0.000167517773999542
"524","HALLMARK_E2F_TARGETS","Brain Lower Grade Glioma",0.000166743621602337
"525","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Uterine Corpus Endometrial Carcinoma",0.000166560160189821
"526","HALLMARK_INTERFERON_ALPHA_RESPONSE","Ovarian Serous Cystadenocarcinoma",0.000166530911631833
"527","HALLMARK_BILE_ACID_METABOLISM","Lung Adenocarcinoma",0.000166530773982582
"528","HALLMARK_APICAL_SURFACE","Stomach Adenocarcinoma",0.000166438241314546
"529","HALLMARK_ADIPOGENESIS","Colon Adenocarcinoma",0.000166070340465439
"530","HALLMARK_COMPLEMENT","Brain Lower Grade Glioma",0.000165756354130775
"531","HALLMARK_ADIPOGENESIS","Brain Lower Grade Glioma",0.000165114514303071
"532","HALLMARK_HEDGEHOG_SIGNALING","Lung Adenocarcinoma",0.000163534114254582
"533","HALLMARK_PROTEIN_SECRETION","Colon Adenocarcinoma",0.000162872430996158
"534","HALLMARK_XENOBIOTIC_METABOLISM","Brain Lower Grade Glioma",0.000160623817779362
"535","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Bladder Urothelial Carcinoma",0.000160123265079929
"536","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Breast Invasive Carcinoma",0.000160020846221224
"537","HALLMARK_APOPTOSIS","Kidney Renal Clear Cell Carcinoma",0.000159920652970098
"538","HALLMARK_INTERFERON_GAMMA_RESPONSE","Liver Hepatocellular Carcinoma",0.000159649754744731
"539","HALLMARK_MYC_TARGETS_V2","Breast Invasive Carcinoma",0.000159601934495576
"540","HALLMARK_DNA_REPAIR","Colon Adenocarcinoma",0.000158696133257155
"541","HALLMARK_PROTEIN_SECRETION","Bladder Urothelial Carcinoma",0.00015862777736355
"542","HALLMARK_COMPLEMENT","Liver Hepatocellular Carcinoma",0.000158098279397919
"543","HALLMARK_KRAS_SIGNALING_DN","Kidney Renal Clear Cell Carcinoma",0.000157701520330571
"544","HALLMARK_GLYCOLYSIS","Breast Invasive Carcinoma",0.000156928962815298
"545","HALLMARK_HEDGEHOG_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000156570134800576
"546","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Breast Invasive Carcinoma",0.00015651867278811
"547","HALLMARK_GLYCOLYSIS","Kidney Renal Clear Cell Carcinoma",0.000155711203165678
"548","HALLMARK_KRAS_SIGNALING_UP","Kidney Renal Papillary Cell Carcinoma",0.000155454945132006
"549","HALLMARK_HEME_METABOLISM","Kidney Renal Clear Cell Carcinoma",0.000155059681461626
"550","HALLMARK_MTORC1_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000154934678666813
"551","HALLMARK_G2M_CHECKPOINT","Breast Invasive Carcinoma",0.000154899682722555
"552","HALLMARK_UV_RESPONSE_UP","Kidney Renal Papillary Cell Carcinoma",0.000154862286407814
"553","HALLMARK_NOTCH_SIGNALING","Stomach Adenocarcinoma",0.000154796148302855
"554","HALLMARK_ADIPOGENESIS","Liver Hepatocellular Carcinoma",0.000154315346744775
"555","HALLMARK_PEROXISOME","Liver Hepatocellular Carcinoma",0.000154139653934589
"556","HALLMARK_FATTY_ACID_METABOLISM","Liver Hepatocellular Carcinoma",0.000153325240603379
"557","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Breast Invasive Carcinoma",0.00015330489089938
"558","HALLMARK_DNA_REPAIR","Liver Hepatocellular Carcinoma",0.000153108985771106
"559","HALLMARK_MYC_TARGETS_V1","Colon Adenocarcinoma",0.000152930552171027
"560","HALLMARK_MITOTIC_SPINDLE","Brain Lower Grade Glioma",0.000152795557316705
"561","HALLMARK_IL2_STAT5_SIGNALING","Breast Invasive Carcinoma",0.000152274376132683
"562","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Lung Adenocarcinoma",0.000152255765398081
"563","HALLMARK_P53_PATHWAY","Kidney Renal Papillary Cell Carcinoma",0.000152215114656903
"564","HALLMARK_FATTY_ACID_METABOLISM","Brain Lower Grade Glioma",0.000151034520648342
"565","HALLMARK_DNA_REPAIR","Uterine Corpus Endometrial Carcinoma",0.00014920840216162
"566","HALLMARK_MYC_TARGETS_V1","Lung Squamous Cell Carcinoma",0.000147737753415929
"567","HALLMARK_INFLAMMATORY_RESPONSE","Kidney Renal Papillary Cell Carcinoma",0.000147716720769962
"568","HALLMARK_NOTCH_SIGNALING","Head and Neck Squamous Cell Carcinoma",0.000147113306873319
"569","HALLMARK_INTERFERON_GAMMA_RESPONSE","Colon Adenocarcinoma",0.00014659957100566
"570","HALLMARK_IL2_STAT5_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000146504546595656
"571","HALLMARK_INTERFERON_ALPHA_RESPONSE","Kidney Renal Papillary Cell Carcinoma",0.000146344192118171
"572","HALLMARK_DNA_REPAIR","Kidney Renal Papillary Cell Carcinoma",0.000146205744934946
"573","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Uterine Corpus Endometrial Carcinoma",0.000146196964719165
"574","HALLMARK_PANCREAS_BETA_CELLS","Breast Invasive Carcinoma",0.000145558429156329
"575","HALLMARK_UV_RESPONSE_UP","Breast Invasive Carcinoma",0.000145057871940542
"576","HALLMARK_APICAL_SURFACE","Bladder Urothelial Carcinoma",0.000144394739900707
"577","HALLMARK_MTORC1_SIGNALING","Breast Invasive Carcinoma",0.000144047998052564
"578","HALLMARK_E2F_TARGETS","Lung Adenocarcinoma",0.000143549412471684
"579","HALLMARK_APOPTOSIS","Breast Invasive Carcinoma",0.00014265623612059
"580","HALLMARK_HEDGEHOG_SIGNALING","Breast Invasive Carcinoma",0.000142497178935972
"581","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Kidney Renal Papillary Cell Carcinoma",0.000142222634086959
"582","HALLMARK_COAGULATION","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",0.000142177909931395
"583","HALLMARK_COMPLEMENT","Breast Invasive Carcinoma",0.000142046471337103
"584","HALLMARK_TGF_BETA_SIGNALING","Breast Invasive Carcinoma",0.000141404783985666
"585","HALLMARK_MITOTIC_SPINDLE","Uterine Corpus Endometrial Carcinoma",0.000140075048125493
"586","HALLMARK_MYC_TARGETS_V1","Lung Adenocarcinoma",0.000139801954752118
"587","HALLMARK_TGF_BETA_SIGNALING","Kidney Renal Clear Cell Carcinoma",0.000139336675405505
"588","HALLMARK_MITOTIC_SPINDLE","Head and Neck Squamous Cell Carcinoma",0.000139003167600175
"589","HALLMARK_ESTROGEN_RESPONSE_LATE","Kidney Renal Papillary Cell Carcinoma",0.000138643471053172
"590","HALLMARK_PANCREAS_BETA_CELLS","Head and Neck Squamous Cell Carcinoma",0.000138258354951596
"591","HALLMARK_COAGULATION","Kidney Renal Clear Cell Carcinoma",0.000137840648649507
"592","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000137127011119165
"593","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Breast Invasive Carcinoma",0.000137119753091722
"594","HALLMARK_ANGIOGENESIS","Breast Invasive Carcinoma",0.00013680171643132
"595","HALLMARK_SPERMATOGENESIS","Breast Invasive Carcinoma",0.000136636980253526
"596","HALLMARK_UV_RESPONSE_UP","Brain Lower Grade Glioma",0.000136289990216399
"597","HALLMARK_ALLOGRAFT_REJECTION","Kidney Renal Papillary Cell Carcinoma",0.000135589415383381
"598","HALLMARK_HEME_METABOLISM","Stomach Adenocarcinoma",0.000135245376275063
"599","HALLMARK_UV_RESPONSE_DN","Liver Hepatocellular Carcinoma",0.000135228718248976
"600","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Breast Invasive Carcinoma",0.000134084093447691
"601","HALLMARK_PANCREAS_BETA_CELLS","Lung Adenocarcinoma",0.000133078470765951
"602","HALLMARK_E2F_TARGETS","Breast Invasive Carcinoma",0.000132589959558074
"603","HALLMARK_NOTCH_SIGNALING","Ovarian Serous Cystadenocarcinoma",0.000132213570644601
"604","HALLMARK_ADIPOGENESIS","Kidney Renal Papillary Cell Carcinoma",0.000132184343721812
"605","HALLMARK_MYOGENESIS","Breast Invasive Carcinoma",0.000130645447398776
"606","HALLMARK_NOTCH_SIGNALING","Lung Adenocarcinoma",0.000130017661909795
"607","HALLMARK_KRAS_SIGNALING_UP","Breast Invasive Carcinoma",0.000129975323507572
"608","HALLMARK_DNA_REPAIR","Breast Invasive Carcinoma",0.000129871944153402
"609","HALLMARK_NOTCH_SIGNALING","Lung Squamous Cell Carcinoma",0.000129810031082728
"610","HALLMARK_APICAL_SURFACE","Brain Lower Grade Glioma",0.000129228758883325
"611","HALLMARK_E2F_TARGETS","Kidney Renal Clear Cell Carcinoma",0.000129013196207013
"612","HALLMARK_INFLAMMATORY_RESPONSE","Breast Invasive Carcinoma",0.000128397687090448
"613","HALLMARK_HEME_METABOLISM","Breast Invasive Carcinoma",0.000127937582360264
"614","HALLMARK_ESTROGEN_RESPONSE_EARLY","Kidney Renal Papillary Cell Carcinoma",0.000127907356431492
"615","HALLMARK_P53_PATHWAY","Breast Invasive Carcinoma",0.00012757440501833
"616","HALLMARK_APOPTOSIS","Kidney Renal Papillary Cell Carcinoma",0.000127107078106889
"617","HALLMARK_ANDROGEN_RESPONSE","Uterine Corpus Endometrial Carcinoma",0.000127055692481356
"618","HALLMARK_UV_RESPONSE_DN","Uterine Corpus Endometrial Carcinoma",0.000126198656556882
"619","HALLMARK_E2F_TARGETS","Lung Squamous Cell Carcinoma",0.000125708858759561
"620","HALLMARK_MYC_TARGETS_V2","Uterine Corpus Endometrial Carcinoma",0.000125376309290585
"621","HALLMARK_COAGULATION","Breast Invasive Carcinoma",0.000125198580330682
"622","HALLMARK_BILE_ACID_METABOLISM","Kidney Renal Papillary Cell Carcinoma",0.000125180203718124
"623","HALLMARK_UV_RESPONSE_UP","Stomach Adenocarcinoma",0.000124782603865249
"624","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Uterine Corpus Endometrial Carcinoma",0.000124111087343361
"625","HALLMARK_ESTROGEN_RESPONSE_EARLY","Uterine Corpus Endometrial Carcinoma",0.000123792642702655
"626","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Colon Adenocarcinoma",0.000122662871004548
"627","HALLMARK_MITOTIC_SPINDLE","Breast Invasive Carcinoma",0.00012216901350841
"628","HALLMARK_UV_RESPONSE_DN","Kidney Renal Papillary Cell Carcinoma",0.000122074811981891
"629","HALLMARK_IL6_JAK_STAT3_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000121029880764762
"630","HALLMARK_G2M_CHECKPOINT","Uterine Corpus Endometrial Carcinoma",0.000120907148809721
"631","HALLMARK_ADIPOGENESIS","Breast Invasive Carcinoma",0.00012057002080078
"632","HALLMARK_KRAS_SIGNALING_DN","Breast Invasive Carcinoma",0.000119748557148741
"633","HALLMARK_ANDROGEN_RESPONSE","Kidney Renal Papillary Cell Carcinoma",0.000119713364889767
"634","HALLMARK_APICAL_JUNCTION","Stomach Adenocarcinoma",0.000119653821358204
"635","HALLMARK_MTORC1_SIGNALING","Kidney Renal Clear Cell Carcinoma",0.000119579600172394
"636","HALLMARK_INTERFERON_GAMMA_RESPONSE","Breast Invasive Carcinoma",0.000119388292911904
"637","HALLMARK_E2F_TARGETS","Uterine Corpus Endometrial Carcinoma",0.000118854089080752
"638","HALLMARK_E2F_TARGETS","Stomach Adenocarcinoma",0.000118784795093077
"639","HALLMARK_HYPOXIA","Breast Invasive Carcinoma",0.000118347438679794
"640","HALLMARK_SPERMATOGENESIS","Kidney Renal Papillary Cell Carcinoma",0.000118289696216934
"641","HALLMARK_SPERMATOGENESIS","Uterine Corpus Endometrial Carcinoma",0.000117964041539318
"642","HALLMARK_KRAS_SIGNALING_DN","Kidney Renal Papillary Cell Carcinoma",0.000117335201821438
"643","HALLMARK_ALLOGRAFT_REJECTION","Breast Invasive Carcinoma",0.0001171198075793
"644","HALLMARK_ESTROGEN_RESPONSE_LATE","Kidney Renal Clear Cell Carcinoma",0.000116874645838793
"645","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Breast Invasive Carcinoma",0.000116848675844908
"646","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Uterine Corpus Endometrial Carcinoma",0.000116080225126251
"647","HALLMARK_APICAL_SURFACE","Breast Invasive Carcinoma",0.000116053548625026
"648","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Breast Invasive Carcinoma",0.000115636515507992
"649","HALLMARK_ESTROGEN_RESPONSE_LATE","Uterine Corpus Endometrial Carcinoma",0.000115330766802736
"650","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Uterine Corpus Endometrial Carcinoma",0.000115136160584757
"651","HALLMARK_NOTCH_SIGNALING","Breast Invasive Carcinoma",0.000115058346789149
"652","HALLMARK_XENOBIOTIC_METABOLISM","Kidney Renal Papillary Cell Carcinoma",0.000114726863437274
"653","HALLMARK_COMPLEMENT","Kidney Renal Papillary Cell Carcinoma",0.000114451824195811
"654","HALLMARK_NOTCH_SIGNALING","Kidney Renal Papillary Cell Carcinoma",0.000113985892241695
"655","HALLMARK_ADIPOGENESIS","Kidney Renal Clear Cell Carcinoma",0.000111262865704178
"656","HALLMARK_APICAL_SURFACE","Liver Hepatocellular Carcinoma",0.000110090322386223
"657","HALLMARK_MYC_TARGETS_V1","Kidney Renal Clear Cell Carcinoma",0.000109529914191135
"658","HALLMARK_MTORC1_SIGNALING","Uterine Corpus Endometrial Carcinoma",0.000109058797201223
"659","HALLMARK_HYPOXIA","Kidney Renal Papillary Cell Carcinoma",0.000108813893909447
"660","HALLMARK_APOPTOSIS","Uterine Corpus Endometrial Carcinoma",0.000107964135767654
"661","HALLMARK_UV_RESPONSE_DN","Kidney Renal Clear Cell Carcinoma",0.000107685536146164
"662","HALLMARK_INFLAMMATORY_RESPONSE","Kidney Renal Clear Cell Carcinoma",0.000106862177560619
"663","HALLMARK_APICAL_SURFACE","Uterine Corpus Endometrial Carcinoma",0.000106552888604452
"664","HALLMARK_IL6_JAK_STAT3_SIGNALING","Uterine Corpus Endometrial Carcinoma",0.000106423968875898
"665","HALLMARK_APICAL_JUNCTION","Kidney Renal Clear Cell Carcinoma",0.0001059186942557
"666","HALLMARK_UV_RESPONSE_UP","Uterine Corpus Endometrial Carcinoma",0.000105608381797056
"667","HALLMARK_ANDROGEN_RESPONSE","Breast Invasive Carcinoma",0.000105562961791874
"668","HALLMARK_PROTEIN_SECRETION","Breast Invasive Carcinoma",0.000103942620488611
"669","HALLMARK_COAGULATION","Kidney Renal Papillary Cell Carcinoma",0.00010349001557246
"670","HALLMARK_APICAL_JUNCTION","Breast Invasive Carcinoma",0.000102903964500894
"671","HALLMARK_COAGULATION","Liver Hepatocellular Carcinoma",0.000102676543555146
"672","HALLMARK_ADIPOGENESIS","Uterine Corpus Endometrial Carcinoma",0.000102618797575831
"673","HALLMARK_HEME_METABOLISM","Liver Hepatocellular Carcinoma",0.000102384595317152
"674","HALLMARK_HEDGEHOG_SIGNALING","Uterine Corpus Endometrial Carcinoma",0.000102328630176711
"675","HALLMARK_IL2_STAT5_SIGNALING","Uterine Corpus Endometrial Carcinoma",0.000101564657874347
"676","HALLMARK_IL2_STAT5_SIGNALING","Kidney Renal Clear Cell Carcinoma",0.000101456524361563
"677","HALLMARK_KRAS_SIGNALING_UP","Kidney Renal Clear Cell Carcinoma",0.000100561052751846
"678","HALLMARK_GLYCOLYSIS","Stomach Adenocarcinoma",0.000100498276664345
"679","HALLMARK_IL6_JAK_STAT3_SIGNALING","Kidney Renal Clear Cell Carcinoma",0.000100037638840722
"680","HALLMARK_FATTY_ACID_METABOLISM","Kidney Renal Papillary Cell Carcinoma",9.8412288964934e-05
"681","HALLMARK_ESTROGEN_RESPONSE_EARLY","Kidney Renal Clear Cell Carcinoma",9.73218614851006e-05
"682","HALLMARK_HYPOXIA","Uterine Corpus Endometrial Carcinoma",9.71030399585398e-05
"683","HALLMARK_XENOBIOTIC_METABOLISM","Kidney Renal Clear Cell Carcinoma",9.67393638327343e-05
"684","HALLMARK_ALLOGRAFT_REJECTION","Uterine Corpus Endometrial Carcinoma",9.53633371675603e-05
"685","HALLMARK_PROTEIN_SECRETION","Kidney Renal Clear Cell Carcinoma",9.51573216857821e-05
"686","HALLMARK_PROTEIN_SECRETION","Uterine Corpus Endometrial Carcinoma",9.46064620404103e-05
"687","HALLMARK_SPERMATOGENESIS","Liver Hepatocellular Carcinoma",9.41857929296456e-05
"688","HALLMARK_NOTCH_SIGNALING","Uterine Corpus Endometrial Carcinoma",9.23861974727175e-05
"689","HALLMARK_HEME_METABOLISM","Uterine Corpus Endometrial Carcinoma",9.16794559005758e-05
"690","HALLMARK_HYPOXIA","Liver Hepatocellular Carcinoma",9.14634421668867e-05
"691","HALLMARK_XENOBIOTIC_METABOLISM","Breast Invasive Carcinoma",9.01953625764343e-05
"692","HALLMARK_INFLAMMATORY_RESPONSE","Uterine Corpus Endometrial Carcinoma",9.00872680269643e-05
"693","HALLMARK_FATTY_ACID_METABOLISM","Breast Invasive Carcinoma",9.00567663518233e-05
"694","HALLMARK_P53_PATHWAY","Kidney Renal Clear Cell Carcinoma",8.98763104756324e-05
"695","HALLMARK_GLYCOLYSIS","Uterine Corpus Endometrial Carcinoma",8.8940531342706e-05
"696","HALLMARK_INTERFERON_ALPHA_RESPONSE","Colon Adenocarcinoma",8.87583084030735e-05
"697","HALLMARK_PANCREAS_BETA_CELLS","Kidney Renal Clear Cell Carcinoma",8.70774600368305e-05
"698","HALLMARK_BILE_ACID_METABOLISM","Breast Invasive Carcinoma",8.69038129532124e-05
"699","HALLMARK_DNA_REPAIR","Kidney Renal Clear Cell Carcinoma",8.6210673064115e-05
"700","HALLMARK_PEROXISOME","Breast Invasive Carcinoma",8.31130536970087e-05
"701","HALLMARK_PROTEIN_SECRETION","Kidney Renal Papillary Cell Carcinoma",8.2599055695181e-05
"702","HALLMARK_KRAS_SIGNALING_UP","Uterine Corpus Endometrial Carcinoma",8.22913122428334e-05
"703","HALLMARK_APICAL_JUNCTION","Uterine Corpus Endometrial Carcinoma",8.18245866973545e-05
"704","HALLMARK_MYC_TARGETS_V1","Uterine Corpus Endometrial Carcinoma",8.16987711626836e-05
"705","HALLMARK_MYOGENESIS","Uterine Corpus Endometrial Carcinoma",8.05211826362627e-05
"706","HALLMARK_COAGULATION","Uterine Corpus Endometrial Carcinoma",7.99073447304835e-05
"707","HALLMARK_APICAL_JUNCTION","Liver Hepatocellular Carcinoma",7.8970398344106e-05
"708","HALLMARK_MITOTIC_SPINDLE","Liver Hepatocellular Carcinoma",7.8874576416823e-05
"709","HALLMARK_KRAS_SIGNALING_DN","Uterine Corpus Endometrial Carcinoma",7.58233562020745e-05
"710","HALLMARK_INTERFERON_ALPHA_RESPONSE","Breast Invasive Carcinoma",7.47481850874984e-05
"711","HALLMARK_ALLOGRAFT_REJECTION","Kidney Renal Clear Cell Carcinoma",7.43469802138949e-05
"712","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Breast Invasive Carcinoma",7.34381153374896e-05
"713","HALLMARK_MYC_TARGETS_V2","Lung Squamous Cell Carcinoma",7.32004560241214e-05
"714","HALLMARK_INTERFERON_GAMMA_RESPONSE","Kidney Renal Clear Cell Carcinoma",7.12228090717235e-05
"715","HALLMARK_COMPLEMENT","Uterine Corpus Endometrial Carcinoma",7.09840514432346e-05
"716","HALLMARK_INTERFERON_GAMMA_RESPONSE","Uterine Corpus Endometrial Carcinoma",6.86807807683573e-05
"717","HALLMARK_HYPOXIA","Kidney Renal Clear Cell Carcinoma",6.86674349662163e-05
"718","HALLMARK_COMPLEMENT","Kidney Renal Clear Cell Carcinoma",6.85511674048646e-05
"719","HALLMARK_XENOBIOTIC_METABOLISM","Uterine Corpus Endometrial Carcinoma",6.55960930400364e-05
"720","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Uterine Corpus Endometrial Carcinoma",6.42608023862211e-05
"721","HALLMARK_PROTEIN_SECRETION","Liver Hepatocellular Carcinoma",6.42521501151953e-05
"722","HALLMARK_FATTY_ACID_METABOLISM","Uterine Corpus Endometrial Carcinoma",6.09528794139679e-05
"723","HALLMARK_PEROXISOME","Uterine Corpus Endometrial Carcinoma",6.01415076259372e-05
"724","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Liver Hepatocellular Carcinoma",5.92030552440274e-05
"725","HALLMARK_ANGIOGENESIS","Uterine Corpus Endometrial Carcinoma",5.74148787983336e-05
"726","HALLMARK_TGF_BETA_SIGNALING","Uterine Corpus Endometrial Carcinoma",5.69952849814009e-05
"727","HALLMARK_MITOTIC_SPINDLE","Kidney Renal Clear Cell Carcinoma",5.48640703066086e-05
"728","HALLMARK_ANGIOGENESIS","Thyroid Carcinoma",5.4557375525211e-05
"729","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Uterine Corpus Endometrial Carcinoma",5.45204726742204e-05
"730","HALLMARK_MYC_TARGETS_V1","Stomach Adenocarcinoma",5.35921724561045e-05
"731","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Prostate Adenocarcinoma",5.34119022876959e-05
"732","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Uterine Corpus Endometrial Carcinoma",5.26171204297456e-05
"733","HALLMARK_BILE_ACID_METABOLISM","Uterine Corpus Endometrial Carcinoma",4.63308027074868e-05
"734","HALLMARK_DNA_REPAIR","Prostate Adenocarcinoma",4.46632560243436e-05
"735","HALLMARK_PANCREAS_BETA_CELLS","Uterine Corpus Endometrial Carcinoma",4.42791947849778e-05
"736","HALLMARK_NOTCH_SIGNALING","Thyroid Carcinoma",4.28809250958948e-05
"737","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Prostate Adenocarcinoma",4.26294641351627e-05
"738","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Prostate Adenocarcinoma",4.24123728963346e-05
"739","HALLMARK_HEDGEHOG_SIGNALING","Thyroid Carcinoma",4.2125324767036e-05
"740","HALLMARK_PEROXISOME","Kidney Renal Papillary Cell Carcinoma",3.81909627452522e-05
"741","HALLMARK_HEDGEHOG_SIGNALING","Prostate Adenocarcinoma",3.74503723061422e-05
"742","HALLMARK_IL6_JAK_STAT3_SIGNALING","Prostate Adenocarcinoma",3.72026681127702e-05
"743","HALLMARK_NOTCH_SIGNALING","Liver Hepatocellular Carcinoma",3.71593864069553e-05
"744","HALLMARK_MYC_TARGETS_V1","Prostate Adenocarcinoma",3.69075525557113e-05
"745","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Prostate Adenocarcinoma",3.55260286039964e-05
"746","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Kidney Renal Papillary Cell Carcinoma",3.39292404091088e-05
"747","HALLMARK_G2M_CHECKPOINT","Prostate Adenocarcinoma",3.35199640262164e-05
"748","HALLMARK_P53_PATHWAY","Uterine Corpus Endometrial Carcinoma",3.33574742510192e-05
"749","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Kidney Renal Clear Cell Carcinoma",3.30552435317263e-05
"750","HALLMARK_UV_RESPONSE_UP","Prostate Adenocarcinoma",3.28772844575894e-05
"751","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Prostate Adenocarcinoma",3.25557997660091e-05
"752","HALLMARK_NOTCH_SIGNALING","Prostate Adenocarcinoma",3.14949965613368e-05
"753","HALLMARK_INTERFERON_ALPHA_RESPONSE","Uterine Corpus Endometrial Carcinoma",3.11556978862529e-05
"754","HALLMARK_HEME_METABOLISM","Prostate Adenocarcinoma",3.08707438607069e-05
"755","HALLMARK_GLYCOLYSIS","Prostate Adenocarcinoma",2.99346653888837e-05
"756","HALLMARK_KRAS_SIGNALING_DN","Prostate Adenocarcinoma",2.95970148088219e-05
"757","HALLMARK_ANGIOGENESIS","Prostate Adenocarcinoma",2.91507557808047e-05
"758","HALLMARK_MTORC1_SIGNALING","Prostate Adenocarcinoma",2.90777937508123e-05
"759","HALLMARK_E2F_TARGETS","Prostate Adenocarcinoma",2.89971692984512e-05
"760","HALLMARK_PROTEIN_SECRETION","Prostate Adenocarcinoma",2.85684972870425e-05
"761","HALLMARK_CHOLESTEROL_HOMEOSTASIS","Thyroid Carcinoma",2.83294432764799e-05
"762","HALLMARK_ANDROGEN_RESPONSE","Prostate Adenocarcinoma",2.78021191716961e-05
"763","HALLMARK_SPERMATOGENESIS","Prostate Adenocarcinoma",2.77366869498372e-05
"764","HALLMARK_PANCREAS_BETA_CELLS","Prostate Adenocarcinoma",2.76236037871297e-05
"765","HALLMARK_KRAS_SIGNALING_UP","Prostate Adenocarcinoma",2.74486715616124e-05
"766","HALLMARK_MYC_TARGETS_V2","Prostate Adenocarcinoma",2.68858032367217e-05
"767","HALLMARK_ALLOGRAFT_REJECTION","Prostate Adenocarcinoma",2.68661932243688e-05
"768","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Kidney Renal Clear Cell Carcinoma",2.64400808283977e-05
"769","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Prostate Adenocarcinoma",2.63754882609009e-05
"770","HALLMARK_MYOGENESIS","Prostate Adenocarcinoma",2.63726602518918e-05
"771","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Thyroid Carcinoma",2.6223398492549e-05
"772","HALLMARK_INFLAMMATORY_RESPONSE","Prostate Adenocarcinoma",2.58213489488701e-05
"773","HALLMARK_TGF_BETA_SIGNALING","Thyroid Carcinoma",2.58168696679865e-05
"774","HALLMARK_KRAS_SIGNALING_UP","Thyroid Carcinoma",2.5720006758066e-05
"775","HALLMARK_SPERMATOGENESIS","Kidney Renal Clear Cell Carcinoma",2.5450434986051e-05
"776","HALLMARK_KRAS_SIGNALING_DN","Thyroid Carcinoma",2.54494321122954e-05
"777","HALLMARK_ESTROGEN_RESPONSE_LATE","Prostate Adenocarcinoma",2.53658106616198e-05
"778","HALLMARK_MYOGENESIS","Thyroid Carcinoma",2.53137910901878e-05
"779","HALLMARK_COMPLEMENT","Prostate Adenocarcinoma",2.47888794006752e-05
"780","HALLMARK_FATTY_ACID_METABOLISM","Prostate Adenocarcinoma",2.45168997014933e-05
"781","HALLMARK_INTERFERON_GAMMA_RESPONSE","Prostate Adenocarcinoma",2.3849405172723e-05
"782","HALLMARK_COMPLEMENT","Thyroid Carcinoma",2.36719004627509e-05
"783","HALLMARK_TNFA_SIGNALING_VIA_NFKB","Thyroid Carcinoma",2.33417942321736e-05
"784","HALLMARK_P53_PATHWAY","Thyroid Carcinoma",2.33241599285572e-05
"785","HALLMARK_IL2_STAT5_SIGNALING","Prostate Adenocarcinoma",2.31563921482451e-05
"786","HALLMARK_XENOBIOTIC_METABOLISM","Prostate Adenocarcinoma",2.25076644884105e-05
"787","HALLMARK_IL6_JAK_STAT3_SIGNALING","Thyroid Carcinoma",2.22825472880721e-05
"788","HALLMARK_PANCREAS_BETA_CELLS","Thyroid Carcinoma",2.22068884400564e-05
"789","HALLMARK_TGF_BETA_SIGNALING","Prostate Adenocarcinoma",2.19689560748746e-05
"790","HALLMARK_APOPTOSIS","Prostate Adenocarcinoma",2.16095003043672e-05
"791","HALLMARK_UV_RESPONSE_UP","Thyroid Carcinoma",2.15079448852615e-05
"792","HALLMARK_ADIPOGENESIS","Thyroid Carcinoma",2.13799379634293e-05
"793","HALLMARK_MITOTIC_SPINDLE","Prostate Adenocarcinoma",2.12295998404393e-05
"794","HALLMARK_IL2_STAT5_SIGNALING","Thyroid Carcinoma",2.08679893088193e-05
"795","HALLMARK_GLYCOLYSIS","Thyroid Carcinoma",2.0762961431455e-05
"796","HALLMARK_ALLOGRAFT_REJECTION","Thyroid Carcinoma",2.03034410602942e-05
"797","HALLMARK_BILE_ACID_METABOLISM","Prostate Adenocarcinoma",2.01554582280375e-05
"798","HALLMARK_ESTROGEN_RESPONSE_EARLY","Prostate Adenocarcinoma",1.99033578230294e-05
"799","HALLMARK_P53_PATHWAY","Prostate Adenocarcinoma",1.97335784712178e-05
"800","HALLMARK_APICAL_JUNCTION","Prostate Adenocarcinoma",1.96486267045756e-05
"801","HALLMARK_HEME_METABOLISM","Thyroid Carcinoma",1.96467129537825e-05
"802","HALLMARK_UV_RESPONSE_DN","Thyroid Carcinoma",1.95005614536292e-05
"803","HALLMARK_ADIPOGENESIS","Prostate Adenocarcinoma",1.90190668184844e-05
"804","HALLMARK_INFLAMMATORY_RESPONSE","Thyroid Carcinoma",1.89540738812393e-05
"805","HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION","Prostate Adenocarcinoma",1.87543027205435e-05
"806","HALLMARK_PEROXISOME","Prostate Adenocarcinoma",1.8507369676899e-05
"807","HALLMARK_MYC_TARGETS_V2","Thyroid Carcinoma",1.8228784161197e-05
"808","HALLMARK_UV_RESPONSE_DN","Prostate Adenocarcinoma",1.80191127702123e-05
"809","HALLMARK_HYPOXIA","Prostate Adenocarcinoma",1.80064167670119e-05
"810","HALLMARK_UNFOLDED_PROTEIN_RESPONSE","Thyroid Carcinoma",1.7812838616633e-05
"811","HALLMARK_INTERFERON_GAMMA_RESPONSE","Thyroid Carcinoma",1.75798263146807e-05
"812","HALLMARK_G2M_CHECKPOINT","Thyroid Carcinoma",1.74427341500478e-05
"813","HALLMARK_MITOTIC_SPINDLE","Thyroid Carcinoma",1.70210854743025e-05
"814","HALLMARK_APICAL_SURFACE","Kidney Renal Papillary Cell Carcinoma",1.51257216345778e-05
"815","HALLMARK_INTERFERON_ALPHA_RESPONSE","Thyroid Carcinoma",1.4736217404293e-05
"816","HALLMARK_COAGULATION","Prostate Adenocarcinoma",1.42765218158701e-05
"817","HALLMARK_HYPOXIA","Thyroid Carcinoma",1.37291610719744e-05
"818","HALLMARK_MTORC1_SIGNALING","Thyroid Carcinoma",1.31614397569304e-05
"819","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Prostate Adenocarcinoma",1.24244268052843e-05
"820","HALLMARK_ESTROGEN_RESPONSE_LATE","Thyroid Carcinoma",1.08850776833904e-05
"821","HALLMARK_APICAL_SURFACE","Prostate Adenocarcinoma",1.02049354674646e-05
"822","HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY","Thyroid Carcinoma",9.8009572618394e-06
"823","HALLMARK_DNA_REPAIR","Thyroid Carcinoma",8.75046739631134e-06
"824","HALLMARK_APOPTOSIS","Thyroid Carcinoma",7.88739464372864e-06
"825","HALLMARK_COAGULATION","Thyroid Carcinoma",7.46018060693944e-06
"826","HALLMARK_MYC_TARGETS_V1","Thyroid Carcinoma",7.39546408030188e-06
"827","HALLMARK_BILE_ACID_METABOLISM","Kidney Renal Clear Cell Carcinoma",6.09448024381972e-06
"828","HALLMARK_PI3K_AKT_MTOR_SIGNALING","Thyroid Carcinoma",5.66451832108307e-06
"829","HALLMARK_INTERFERON_ALPHA_RESPONSE","Prostate Adenocarcinoma",5.07498682919237e-06
"830","HALLMARK_INTERFERON_ALPHA_RESPONSE","Kidney Renal Clear Cell Carcinoma",3.75147679676946e-06
"831","HALLMARK_PEROXISOME","Kidney Renal Clear Cell Carcinoma",3.02195468774324e-06
"832","HALLMARK_XENOBIOTIC_METABOLISM","Thyroid Carcinoma",2.1594095001515e-06
"833","HALLMARK_BILE_ACID_METABOLISM","Thyroid Carcinoma",1.84399559106192e-06
"834","HALLMARK_PROTEIN_SECRETION","Thyroid Carcinoma",1.48289545905003e-06
"835","HALLMARK_E2F_TARGETS","Thyroid Carcinoma",-3.74290227356623e-07
"836","HALLMARK_PEROXISOME","Thyroid Carcinoma",-1.66682543402266e-06
"837","HALLMARK_ESTROGEN_RESPONSE_EARLY","Thyroid Carcinoma",-2.5654973035307e-06
"838","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Thyroid Carcinoma",-6.65995781545016e-06
"839","HALLMARK_ANDROGEN_RESPONSE","Kidney Renal Clear Cell Carcinoma",-8.06324228027237e-06
"840","HALLMARK_WNT_BETA_CATENIN_SIGNALING","Thyroid Carcinoma",-8.73521287840755e-06
"841","HALLMARK_APICAL_JUNCTION","Thyroid Carcinoma",-9.83430110294323e-06
"842","HALLMARK_APICAL_SURFACE","Thyroid Carcinoma",-9.87914542050586e-06
"843","HALLMARK_ANDROGEN_RESPONSE","Thyroid Carcinoma",-1.4060905847984e-05
"844","HALLMARK_FATTY_ACID_METABOLISM","Thyroid Carcinoma",-1.49878840096642e-05
"845","HALLMARK_SPERMATOGENESIS","Thyroid Carcinoma",-1.82485336425715e-05
"846","HALLMARK_OXIDATIVE_PHOSPHORYLATION","Kidney Renal Clear Cell Carcinoma",-3.20245452925681e-05
"847","HALLMARK_FATTY_ACID_METABOLISM","Kidney Renal Clear Cell Carcinoma",-4.98776227168374e-05
"848","HALLMARK_PANCREAS_BETA_CELLS","Liver Hepatocellular Carcinoma",-6.93042471622533e-05
"849","HALLMARK_APICAL_SURFACE","Kidney Renal Clear Cell Carcinoma",-8.7144158289327e-05
"850","HALLMARK_NOTCH_SIGNALING","Kidney Renal Clear Cell Carcinoma",-0.00010208123750411
